Sonoscape Medical approves 2025 employee incentive plan

Sonoscape Medical Corp. announced the grant of restricted shares and stock options under its 2025 incentive plan, with the grant date set for October 16, 2025. The company will issue 1.914 million restricted shares to 99 participants and 3.9678 million stock options to 306 participants. The restricted shares are priced at CNY 15.93 per share, and stock options are priced at CNY 31.86 per share.

The company's board of directors, supervisory board, and remuneration and assessment committee approved the grants. The total number of incentive recipients was adjusted from 406 to 405 due to one participant's withdrawal. The overall equity volume remains unchanged.

The granted shares and options will vest over four periods, with 25% of the total becoming eligible in each period, starting 12 months after the grant date. Performance hurdles for the 2025-2028 fiscal years, tied to net profit growth (excluding share-based payment expenses), must be met. The company’s net profit, excluding share-based payment expenses, for 2024 was CNY 136.4904 million.